A special European Journal of Rheumatology issue on systemic sclerosis: What and why?

Kaynakça (14)

1. Ota Y, Kuwana M. Endothelial cells and endothelial progenitor cells in the pathogenesis of systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S139-46
2. Ramahi A, Altorok N, Kahaleh B. Epigenetics and systemic sclerosis: An answer to disease onset and evolution?. Eur J Rheumatol 2020; 7(Suppl 3): S147-56
3. Rosa I, Romano E, Fioretto BS, Manetti M. The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S157-64
4. Frommer KW, Neumann E, Müller-Ladner U. Role of adipokines in systemic sclerosis pathogenesis. Eur J Rheumatol 2020; 7(Suppl 3): S165-72
5. Mehta BK, Espinoza ME, Hinchcliff M, Whitfield ML. Molecular “omic” signatures in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S173-80
6. Abignano G, Del Galdo F. Biomarkers as an opportunity to stratify for outcome in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S193-202
7. Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Putative functional pathogenic autoantibodies in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S181-6
8. Volkmann ER, Hoffmann-Vold AM. Gastrointestinal tract microbiota modifications in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S228-36
9. Herrick AL, Dinsdale G, Murray A. New perspectives in the imaging of Raynaud’s phenomenon. Eur J Rheumatol 2020; 7(Suppl 3): S212-21
10. Mavrogeni SI, Buch M, Markousis-Mavrogenis G, Dumitru B, Pugliese NR, Gargani L. The perpetual sword of Damocles: Cardiac involvement in systemic sclerosis and the role of noninvasive imaging modalities in medical decision making. Eur J Rheumatol 2020; 7(Suppl 3): S203-11
11. Brown ZR, Nikpour M. Screening for pulmonary arterial hypertension in systemic sclerosis: Now or never! Eur J Rheumatol 2020; 7(Suppl 3): S187-92
12. Johnson SR, van den Hoogen F, Devakandan K, Matucci-Cerinic, Pope JE. Systemic sclerosis: To subset or not to subset, that is the question. Eur J Rheumatol 2020; 7(Suppl 3): S222-7
13. Bruni C, Furst DE. The burning question: To use or not to use cyclophosphamide in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S237-41
14. Denton CP, Yee P, Ong VH. News and failures from recent treatment trials in systemic sclerosis. Eur J Rheumatol 2020; 7(Suppl 3): S242-8.